Christina Gentry, DVM, DACVM, discusses concurrent diseases and skin emergencies, in a dvm360 interview.

Norman Parathyroid Center, Clayman Thyroid Center, and Carling Adrenal Center Expand Their Lead as the World’s ...

Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...

As part of Thyroid Nodule Awareness Week, Dr. Roy will host a LIVE Q&A session on Facebook February 26 to answer ...

A 15-year study shows that the drug pergolide is an effective treatment for pituitary pars intermedia dysfunction.

Diseases with an endocrine and metabolic component are a growing problem. In this Q&A, Jiajun Zhao, president of Shandong Provincial Hospital, talks about advances in research and treatment. In the ...

NEW HAVEN, CT, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- Yale Associate Research Scientist Investigates ...

From birth-month signatures to global climate gradients, emerging evidence indicates that seasonal light, temperature, and ...

Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...

The next in our series of quick case-based quizzes in dermatology asks – what’s causing this facial rash involving darker ...